Mga Batayang Estadistika
| LEI | 549300NCZD47LEU5XY15 |
| CIK | 1763197 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to ECMOHO Ltd - ADR
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 10, 2023 |
MOHO / ECMOHO Limited / Behealth Ltd - SC 13G/A Passive Investment SC 13G/A 1 tm235916d1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1 )* ECMOHO Limited (Name of Issuer) Class A ordinary shares, par value $0.00001 per share (Title of Class of Securities) 27888P104 ** (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this St |
|
| February 10, 2023 |
EX-99.1 2 tm235916d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on amendment No. 1 to Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be |
|
| February 10, 2023 |
MOHO / ECMOHO Limited / Uhealth Ltd - SC 13G/A Passive Investment SC 13G/A 1 tm235916d2sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3 )* ECMOHO Limited (Name of Issuer) Class A ordinary shares, par value $0.00001 per share (Title of Class of Securities) 27888P104 ** (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this St |
|
| February 10, 2023 |
EX-99.1 2 tm235916d2ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on amendment No. 3 to Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be |
|
| December 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39121 ECMOHO Limited (Exact name of registrant as specified in its chart |
|
| December 9, 2022 |
? As filed with the Securities and Exchange Commission on December 9, 2022 Registration No. |
|
| December 9, 2022 |
As filed with the Securities and Exchange Commission on December 9, 2022 Registration No. |
|
| December 9, 2022 |
As filed with the Securities and Exchange Commission on December 9, 2022 Registration No. |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 5F, 909 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic |
|
| November 4, 2022 |
ECMOHO Limited Announces Second Quarter 2022 Unaudited Financial Results Exhibit 99.1 ECMOHO Limited Announces Second Quarter 2022 Unaudited Financial Results SHANGHAI, CHINA – November 4, 2022 – ECMOHO Limited (MOHOY) (“ECMOHO”, “we” or the “Company”), an integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Financial Highlights · Total n |
|
| September 20, 2022 |
ECMOHO Receives Delisting Notice from Nasdaq Exhibit 99.1 ECMOHO Receives Delisting Notice from Nasdaq SHANGHAI, China, September 20, 2022 (GLOBAL NEWSWIRE) - ECMOHO Limited (the ?Company?) (Nasdaq: MOHO) today announced that on September 14, 2022, it was notified by the Nasdaq Stock Market (?Nasdaq?) that the staff of the Nasdaq Listing Qualifications Department has determined to commence proceedings to delist the American Depositary Shares |
|
| September 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 5F, 909 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People?s Republic |
|
| May 13, 2022 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of ECMOHO Limited (the “Company”) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Leo Zeng, Acting Chief Financial Officer of the Company, certify, pu |
|
| May 13, 2022 |
Consent of PricewaterhouseCoopers Zhong Tian LLP Exhibit 15.4 ? CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-257546 and 333-236027) and Form F-3 (No. 333-257200) of ECMOHO Limited of our report dated June 12, 2020 relating to the financial statements, which appears in this Form 20-F. ? ? /s/ PricewaterhouseCoopers Zhong Tian LLP Sh |
|
| May 13, 2022 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Leo Zeng, certify that: 1. I have reviewed this annual report on Form 20-F of ECMOHO Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the |
|
| May 13, 2022 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of ECMOHO Limited (the “Company”) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zoe Wang, Chief Executive Officer of the Company, certify, pursuant |
|
| May 13, 2022 |
Consent of Commerce & Finance Law Offices Exhibit 15.1 ? May 13, 2022 ? To: ECMOHO Limited 5th Floor, 909 Tianyaoqiao Road Xuhui District Shanghai, 200030 The People?s Republic of China ? Dear Sir/Madam, ? We hereby consent to the references to our firm?s name under the headings ?Item 3 Key Information?D. Risk Factors?Risks Related to Our Corporate Structure?, ?Item 4. Information on the Company?C. Organizational Structure?Contractual Arr |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Table of Contents ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 13, 2022 |
Certification by Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zoe Wang, certify that: 1. I have reviewed this annual report on Form 20-F of ECMOHO Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the |
|
| May 13, 2022 |
EX-15.3 10 moho-20211231xex15d3.htm EXHIBIT 15.3 Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements of Form S-8 (No. 333-236027 and No. 333-257546) and Form F-3 (No. 333-257200) of our report dated May 13, 2022, relating to the consolidated financial statements of ECMOHO Limited and subsidiaries as of De |
|
| May 13, 2022 |
Consent of Walkers (Hong Kong) Exhibit 15.2 13 May 2022 Our Ref: NASD/SSNC/E2208-H20600 The Board of Directors ECMOHO Limited 3rd Floor, 1000 Tianyaoqiao Road Xuhui District Shanghai, 200030 The People’s Republic of China Dear Sir or Madam ECMOHO Limited FORM 20-F We consent to the reference to our firm under the heading “Item 10. Additional Information—E. Taxation” (the "Cayman Islands Taxation Section") in the Annual Report o |
|
| May 13, 2022 |
Description of securities registered under Section 12 of the Securities Exchange Act, as amended Exhibit 2.4 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (the ?Exchange Act?) American Depositary Shares (?ADSs?), each representing four Class A ordinary shares of ECMOHO Limited (the ?company,? ?we? or ?our?) are listed and traded on the Nasdaq Capital Market under the symbol ?MOHO? and, in connection with that listing (but not for trad |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| March 17, 2022 |
ECMOHO Receives Approval to Transfer to Nasdaq Capital Market EXHIBIT 99.1 ECMOHO Receives Approval to Transfer to Nasdaq Capital Market SHANGHAI, China, March 17, 2022 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO? or the ?Company?), an integrated solutions provider in the health and wellness market in China, today announced that on March 16, 2022, the Listing Qualifications department of the Nasdaq Stock Market LLC (?Nasdaq?) approved the Compa |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 5F, 909 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People?s Republic of |
|
| February 11, 2022 |
MOHO / ECMOHO Limited / Uhealth Ltd - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2 )* ECMOHO Limited (Name of Issuer) Class A ordinary shares, par value $0.00001 per share (Title of Class of Securities) 27888P104 ** (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to des |
|
| February 11, 2022 |
Joint Filing Agreement dated February 11, 2022 Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on amendment No. 2 to Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned |
|
| January 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People?s Republic |
|
| December 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People?s Republic |
|
| December 6, 2021 |
ECMOHO Limited Announces the Appointment of independent director of the Board EXHIBIT 99.1 ECMOHO Limited Announces the Appointment of independent director of the Board SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO? or the ?Company?), an integrated solutions provider in the health and wellness market in China, today announced a change in its board of directors (the ?Board?). Mr. Greg Ye tendered to the Board his resignation as an i |
|
| November 30, 2021 |
ECMOHO Limited Announces Third Quarter 2021 Unaudited Financial Results EXHIBIT 99.1 ECMOHO Limited Announces Third Quarter 2021 Unaudited Financial Results SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO?, ?we? or the ?Company?), an integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Operatio |
|
| November 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People?s Republic |
|
| September 21, 2021 |
ECMOHO Limited Announces Receipt of Minimum Bid Price Notice From NASDAQ EXHIBIT 99.1 ECMOHO Limited Announces Receipt of Minimum Bid Price Notice From NASDAQ SHANGHAI, China, Sept. 21, 2021 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO?, ?we? or the ?Company?), an integrated solutions provider in the health and wellness market in China, today announced that it received a notification letter dated September 16, 2021 (the ?Deficiency Letter?) from the Listin |
|
| September 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People?s Republi |
|
| August 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People?s Republic o |
|
| August 31, 2021 |
ECMOHO Limited Announces Second Quarter 2021 Unaudited Financial Results EXHIBIT 99.1 ECMOHO Limited Announces Second Quarter 2021 Unaudited Financial Results SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO?, ?we? or the ?Company?), a leading integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Ope |
|
| August 5, 2021 |
Exhibit 99.1 ECMOHO Limited Announces Closing of US$9 Million Underwritten Public Offering of American Depositary Shares SHANGHAI, China, August 5, 2021 (GLOBE NEWSWIRE) ? ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO? or the ?Company?), an integrated solutions provider in the health and wellness market in China, today announced the closing of an underwritten public offering of 10 million American Deposi |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-39121 ECMOHO LIMITED (Exact name of registrant as specified in its charter) 3F, 1000 Tianyaoqiao Road Xuhui District, Shanghai, 200030 People?s Republic |
|
| August 3, 2021 |
ECMOHO Limited Announces Proposed Underwritten Public Offering of American Depositary Shares Exhibit 99.1 ECMOHO Limited Announces Proposed Underwritten Public Offering of American Depositary Shares SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) ? ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO? or the ?Company?), a leading integrated solutions provider in the health and wellness market in China, today announced that it intends to offer American depositary shares, or ADSs, each representing four |
|
| August 3, 2021 |
Exhibit 99.2 ECMOHO Limited Announces Pricing of US$9 Million Underwritten Public Offering of American Depositary Shares SHANGHAI, China, August 3, 2021 (GLOBE NEWSWIRE) ? ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO? or the ?Company?), an integrated solutions provider in the health and wellness market in China, today announced the pricing of an underwritten public offering of 10 million American Deposi |
|
| August 3, 2021 |
Underwriting Agreement between ECMOHO Limited and Aegis Capital Corp. dated August 3, 2021 EX-1.1 2 d365462dex11.htm EX-1.1 Exhibit 1.1 UNDERWRITING AGREEMENT between ECMOHO Limited and AEGIS CAPITAL CORP., as Representative of the Several Underwriters ECMOHO LIMITED UNDERWRITING AGREEMENT New York, New York August 3, 2021 Aegis Capital Corp. As Representative of the several Underwriters named on Schedule 1 attached hereto 810 Seventh Avenue, 18th Floor New York, New York 10019 Ladies a |
|
| August 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-39121 ECMOHO LIMITED (Exact name of registrant as specified in its charter) 3F, 1000 Tianyaoqiao Road Xuhui District, Shanghai, 200030 People?s Republic |
|
| August 3, 2021 |
10,000,000 American Depositary Shares Representing 40,000,000 Class A Ordinary Shares ECMOHO Limited Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-257200 (To Prospectus dated June 21, 2021) 10,000,000 American Depositary Shares Representing 40,000,000 Class A Ordinary Shares ECMOHO Limited This is a public offering of 10,000,000 American depositary shares, or ADSs, each representing four Class A ordinary shares, par value US$0.00001 per share, of ECMOHO Limited. We have |
|
| August 2, 2021 |
SUBJECT TO COMPLETION. DATED AUGUST 2, 2021 PRELIMINARY PROSPECTUS SUPPLEMENT Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-257200 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not offering to sell nor do they seek offers to buy these securities in any jurisdiction where the offer or sale is not permitted. SUBJECT TO COMPLETION |
|
| July 2, 2021 |
ECMOHO Limited 3rd Floor, 1000 Tianyaoqiao Road Xuhui District Shanghai, 200030 The People?s Republic of China +86 21-6417-2213 July 2, 2021 VIA EDGAR Division of Corporation Finance Office of Trade & Services Securities and Exchange Commission 100 F Street, N. |
|
| June 30, 2021 |
Exhibit 10.1 ECMOHO LIMITED 2021 OMNIBUS INCENTIVE PLAN GENERAL 1.1Purpose The purpose of the 2021 Omnibus Incentive Plan of ECMOHO Limited (the ?Plan?) is to promote the success and enhance the value of ECMOHO Limited, a company formed under the laws of the Cayman Islands (the ?Company?), by linking the personal interests of the Directors, Employees and Consultants to those of the Company?s share |
|
| June 30, 2021 |
As filed with the Securities and Exchange Commission on June 30, 2021 As filed with the Securities and Exchange Commission on June 30, 2021 Registration No. |
|
| June 21, 2021 |
As filed with the Securities and Exchange Commission on June 21, 2021 Table of Contents As filed with the Securities and Exchange Commission on June 21, 2021 Registration No. |
|
| June 21, 2021 |
Exhibit 4.5 ECMOHO LIMITED INDENTURE Dated as of , 2021 [ ] Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 4 Section 1.3 Incorporation by Reference of Trust Indenture Act 5 Section 1.4 Rules of Construction 5 ARTICLE II THE SECURITIES 6 Section 2.1 Issuable in Series 6 Section 2.2 Establishment of Terms |
|
| June 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-39121 ECMOHO LIMITED (Exact name of registrant as specified in its charter) 3F, 1000 Tianyaoqiao Road Xuhui District, Shanghai, 200030 People?s Republic of |
|
| June 3, 2021 |
ECMOHO Limited Announces First Quarter 2021 Unaudited Financial Results Exhibit 99.1 ECMOHO Limited Announces First Quarter 2021 Unaudited Financial Results SHANGHAI, CHINA ?June 4, 2021 ? ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO? or the ?Company?), a leading integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the first quarter ended March 31, 2021. First Quarter 2021 Operational Highlights ? The |
|
| May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission File Number: 001-39121 ECMOHO LIMITED (Exact name of registrant as specified in its charter) 3F, 1000 Tianyaoqiao Road Xuhui District, Shanghai, 200030 People?s Republic of |
|
| May 13, 2021 |
ECMOHO Limited Announces the Appointment of Chief Financial Officer Exhibit 99.1 ECMOHO Limited Announces the Appointment of Chief Financial Officer SHANGHAI, CHINA ? May 13, 2021 ? ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO? or the ?Company?), a leading integrated solutions provider in the health and wellness market in China, today announced the appointment of Mr. Xin Li as the Chief Financial Officer (?CFO?) of the Company, effective as of May 13, 2021. Mr. Li repla |
|
| April 30, 2021 |
Exhibit 99.1 ECMOHO Announces Fourth Quarter Unaudited Financial Results and Fiscal Year 2020 Audited Financial Results SHANGHAI, CHINA ? April 30, 2021 ? ECMOHO Limited (Nasdaq: MOHO) (?ECMOHO? or the ?Company?), a leading integrated solutions provider in the non-medical health and wellness market in China, today announced its audited financial results for the fiscal year ended December 31, 2020. |
|
| April 30, 2021 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of ECMOHO Limited (the ?Company?) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Leo Zeng, Acting Chief Financial Officer of the Company, certify, pu |
|
| April 30, 2021 |
Exhibit 4.45 NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT (this ?Agreement?) is made as of July 23, 2020, by and among: (1) Anze Premium Health and Beauty Pte. Ltd., a company organized and existing under the laws of the Republic of Singapore (the ?Borrower? or the ?Company?), (2) ECMOHO (Hong Kong) Health Technology Limited, a company organized and existing under the laws of Hong Kong (th |
|
| April 30, 2021 |
Letter from PricewaterhouseCoopers Zhong Tian LLP to the Securities and Exchange Commission Exhibit 16.1 April 30, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by ECMOHO Limited, which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 16F of the Annual Report on Form 20-F for the year ended December 31, 2020 of ECMOHO Limited dated April 30, 2021. We agree with the s |
|
| April 30, 2021 |
Consent of Walkers (Hong Kong) Exhibit 15.2 30 April 2021 Our Ref: JWYL/SSNC/E2208-H20600 The Board of Directors ECMOHO Limited 3rd Floor, 1000 Tianyaoqiao Road Xuhui District Shanghai, 200030 The People?s Republic of China Dear Sir or Madam ECMOHO Limited FORM 20-F We consent to the reference to our firm under the heading ?Item 10. Additional Information?E. Taxation? in the Annual Report on Form 20-F of ECMOHO Limited for the |
|
| April 30, 2021 |
EX-15.3 14 moho-ex1531500.htm EX-15.3 Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Form S-8 Registration Statement pertaining to the 2018 Omnibus Incentive Plans of ECMOHO Limited of our report dated April 30, 2021 relating to the consolidated balance sheet of ECMOHO Limited as of December 31, 2020, and the related consol |
|
| April 30, 2021 |
Consent of PricewaterhouseCoopers Zhong Tian LLP EX-15.4 15 moho-ex1541499.htm EX-15.4 Exhibit 15.4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-236027) of ECMOHO Limited of our report dated June 12, 2020 relating to the financial statements, which appears in this Form 20-F. /s/ PricewaterhouseCoopers Zhong Tian LLP Shanghai, the Pe |
|
| April 30, 2021 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of ECMOHO Limited (the ?Company?) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Zoe Wang, Chief Executive Officer of the Company, certify, pursuant |
|
| April 30, 2021 |
Exhibit 4.41 021 Shanghai Jieshi Technology Co., Ltd. Equity Transfer Agreement This Equity Transfer Agreement (hereinafter referred to as "this Agreement") is signed on July 9, 2020 (hereinafter referred to as "signing date") in Shanghai by and between the following parties: (1) Yijiasancan (Shanghai) E-commerce Co., Ltd., a limited liability company established and existing under Chinese laws, d |
|
| April 30, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2021 Commission File Number: 001-39121 ECMOHO LIMITED (Exact name of registrant as specified in its charter) 3F, 1000 Tianyaoqiao Road Xuhui District, Shanghai, 200030 People?s Republic o |
|
| April 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| April 30, 2021 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Leo Zeng, certify that: 1. I have reviewed this annual report on Form 20-F of ECMOHO Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the |
|
| April 30, 2021 |
Consent of Commerce & Finance Law Offices EX-15.1 12 moho-ex1511214.htm EX-15.1 Exhibit 15.1 April 30, 2021 To: ECMOHO Limited 3rd Floor, 1000 Tianyaoqiao Road Xuhui District Shanghai, 200030 The People’s Republic of China Dear Sir/Madam, We hereby consent to the references to our firm’s name under the headings “Item 3 Key Information—D. Risk Factors—Risks Relating to Our Corporate Structure”, “Item 4. Information on the Company—C. Organi |
|
| April 30, 2021 |
Exhibit 4.42 Shanghai HengshoutangHealth Technology Co., Ltd. Equity Transfer Agreement This Equity Transfer Agreement (hereinafter referred to as "this Agreement") is signed on October 28, 2020 (hereinafter referred to as "signing date") in Shanghai by and between the following parties: (1) Yijiasancan (Shanghai) E-commerce Co., Ltd., a limited liability company established and existing under Chi |
|
| April 30, 2021 |
Certification by Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zoe Wang, certify that: 1. I have reviewed this annual report on Form 20-F of ECMOHO Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the |
|
| April 30, 2021 |
Exhibit 4.44 DATED [July 23?2020] THE PURCHASER and THE SELLER and THE COMPANY SHARE SALE AND PURCHASE AGREEMENT TABLE OF CONTENTS Contents Page 1. Sale and Purchase of Purchased Shares 2 2. Completion 3 3. Post-Completion Undertakings 7 4. Warranties 7 5. Confidentiality 8 6. Variation 9 7. Assignment 9 8. Indulgence, Waiver, etc. 9 9. Costs 9 10. Taxation 9 11. Whole Agreement 9 12. Notices 10 1 |
|
| April 30, 2021 |
Exhibit 4.43 DATED [July 23, 2020] THE INVESTOR and THE FOUNDERS and THE COMPANY SHAREHOLDERS' AGREEMENT TABLE OF CONTENTS Content Page 1. Board of Directors 1 2. Information Rights 3 3. Reserved Matters 3 4. Call Option 4 5. Anti-dilution Provisions 4 6. Undertakings 4 7. Prevalence of Agreement 5 8. Termination 5 9. Variation 5 10. Confidentiality 5 11. Announcements 7 12. Assignment 7 13. No Pa |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1 ) ECMOHO Limited (Name of Issuer) Class A ordinary shares, par value $0.00001 per share (Title of Class of Securities) G29213 108 (CUSIP Number) December 31, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to design |
|
| December 11, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2020 (Commission File No. 001-39121) ECMOHO LIMITED (Translation of registrant's name into English) 3rd Floor 1000 Tianyaoqiao Road Xuhui District, Shanghai 200030 People’s Republic of China +86- |
|
| December 11, 2020 |
EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 ECMOHO LIMITED’s 2020 ANNUAL GENERAL MEETING AS A CAYMAN ISLANDS COMPANY WAS HELD IN SHANGHAI AT 10:00 AM (BEIJING TIME) ON DECEMBER 11, 2020 Meeting address: 2/F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai 200030, People’s Republic of China At the 2020 annual general meeting of shareholders (“AGM”) of ECMOHO Limited (the “Company”), held on Dece |
|
| November 30, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic |
|
| November 30, 2020 |
ECMOHO Announces Third Quarter 2020 Unaudited Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 ECMOHO Announces Third Quarter 2020 Unaudited Financial Results SHANGHAI, China, Nov. 30, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the non-medical health and wellness market in China, today announced its unaudited financial results for the third quarter ended Septemb |
|
| November 9, 2020 |
-Proxy Statement for the 2020 AGM Exhibit 99.2 ECMOHO LIMITED PROXY STATEMENT General The board of directors of ECMOHO Limited., a Cayman Islands company (the “Company” or “we”) is soliciting proxies for the annual general meeting of shareholders of the Company to be held on December 11th, 2020, at 10:00 A.M., Beijing Time (“AGM”). The AGM will be held at 2nd Floor, 1000 Tianyaoqiao Road, Xuhui District, Shanghai 200030, People’s |
|
| November 9, 2020 |
Current Report of Foreign Issuer - FORM 6-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Amendment No. 1 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 (Commission File No. 001-39121) ECMOHO LIMITED (Translation of registrant's name into English) 3rd Floor 1000 Tianyaoqiao Road Xuhui District, Shanghai 200030 People’s Repu |
|
| November 9, 2020 |
-Notice of 2020 Annual General Meeting of Shareholders (the “2020 AGM”) Exhibit 99.1 ECMOHO LIMITED NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 11, 2020 Notice is hereby given that ECMOHO Limited, a Cayman Islands company (the “Company” or “we”), will hold its annual general meeting of shareholders on December 11th, 2020, at 10:00 A.M., Beijing Time (“AGM”). The AGM will be held at 2/F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai 200030 |
|
| November 9, 2020 |
-Depositary’s Notice of the 2020 AGM Exhibit 99.4 ADSs: American Depositary Shares. ADS CUSIP No.: 27888P104. ADS Record Date: November 6, 2020. Meeting Specifics: Annual General Meeting to be held on Friday, December 11, 2020 at 10:00 a.m. (local time) at 2/F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai 200030, People’s Republic of China (the “ Meeting ”). Meeting Agenda: Please refer to the Company’s Notice of Annual General Me |
|
| November 9, 2020 |
-Form of Proxy for the 2020 AGM Exhibit 99.3 ECMOHO LIMITED (incorporated in the Cayman Islands with limited liability) FORM OF PROXY FOR THE ANNUAL GENERAL MEETING to be held on December 11, 2020 (or any adjourned or postponed meeting thereof) I/we, the undersigned acknowledges receipt of the Notice of Annual General Meeting of Shareholders and Proxy Statement and, being the registered holder of Class A Ordinary Shares1, par va |
|
| November 9, 2020 |
-Voting Instructions of American Depositary Shares for the 2020 AGM EX-99.5 6 exh995.htm EXHIBIT 99.5 Exhibit 99.5 Annual General Meeting ECMOHO Limited (the “ Company ”) 27888P104. November 6, 2020. Annual General Meeting to be held on Friday, December 11, 2020 at 10:00 a.m. (local time) 2/F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai 200030, People’s Republic of China (the “ Meeting ”). Please refer to the Company’s Notice of Annual General Meeting and othe |
|
| November 6, 2020 |
Exhibit 99.3 ECMOHO LIMITED (incorporated in the Cayman Islands with limited liability) FORM OF PROXY FOR THE ANNUAL GENERAL MEETING to be held on December 11, 2020 (or any adjourned or postponed meeting thereof) I/we, the undersigned acknowledges receipt of the Notice of Annual General Meeting of Shareholders and Proxy Statement and, being the registered holder of Class A Ordinary Shares1, par va |
|
| November 6, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 (Commission File No. 001-39121) ECMOHO LIMITED (Translation of registrant's name into English) 3rd Floor 1000 Tianyaoqiao Road Xuhui District, Shanghai 200030 People’s Republic of China +86- |
|
| November 6, 2020 |
ECMOHO LIMITED NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 11, 2020 Exhibit 99.1 ECMOHO LIMITED NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 11, 2020 Notice is hereby given that ECMOHO Limited, a Cayman Islands company (the “Company” or “we”), will hold its annual general meeting of shareholders on December 11th, 2020, at 10:00 A.M., Beijing Time (“AGM”). The AGM will be held at 2/F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai 200030 |
|
| November 6, 2020 |
ECMOHO LIMITED PROXY STATEMENT EX-99.2 3 exh992.htm EXHIBIT 99.2 Exhibit 99.2 ECMOHO LIMITED PROXY STATEMENT General The board of directors of ECMOHO Limited., a Cayman Islands company (the “Company” or “we”) is soliciting proxies for the annual general meeting of shareholders of the Company to be held on December 11th, 2020, at 10:00 A.M., Beijing Time (“AGM”). The AGM will be held at 2nd Floor, 1000 Tianyaoqiao Road, Xuhui Di |
|
| November 6, 2020 |
-Voting Instructions of American Depositary Shares for the 2020 AGM EX-99.5 6 exh995.htm EXHIBIT 99.5 Exhibit 99.5 |
|
| November 6, 2020 |
-Depositary’s Notice of 2020 AGM EX-99.4 5 exh994.htm EXHIBIT 99.4 Exhibit 99.4 |
|
| November 5, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 (Commission File No. 001-39121) ECMOHO LIMITED (Translation of registrant's name into English) 3rd Floor 1000 Tianyaoqiao Road Xuhui District, Shanghai 200030 People’s Republic of China +86- |
|
| October 23, 2020 |
ECMOHO Limited Announces Change of Auditor EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 ECMOHO Limited Announces Change of Auditor Shanghai, China – October 23, 2020 – ECMOHO Limited (“ECMOHO” or the “Company”; Nasdaq: MOHO), a leading integrated solution provider in the non-medical health and wellness market in China announced that PricewaterhouseCoopers Zhong Tian LLP (“PwC”) has been dismissed as the Company’s independent auditor, eff |
|
| October 23, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic |
|
| September 16, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republi |
|
| September 16, 2020 |
ECMOHO Announces Second Quarter 2020 Unaudited Financial Results EXHIBIT 99.1 ECMOHO Announces Second Quarter 2020 Unaudited Financial Results SHANGHAI, China, Sept. 15, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the non-medical health and wellness market in China, today announced its unaudited financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Fina |
|
| August 3, 2020 |
ECMOHO Limited Invests in Developer of Chinese Herbal Medicine Based Health and Wellness Products EXHIBIT 99.1 ECMOHO Limited Invests in Developer of Chinese Herbal Medicine Based Health and Wellness Products SHANGHAI, China, Aug. 03, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited ("ECMOHO" or the "Company"; Nasdaq: MOHO) announced today that it has entered into an investment agreement with Anze Premium Health and Beauty Pte. Ltd. (“Anze”), a company involved in the research and development of Chinese |
|
| August 3, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic o |
|
| July 6, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic of |
|
| July 6, 2020 |
ECMOHO Announces First Quarter 2020 Unaudited Financial Results EXHIBIT 99.1 ECMOHO Announces First Quarter 2020 Unaudited Financial Results SHANGHAI, China, July 03, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the non-medical health and wellness market in China, today announced its unaudited financial results for the first quarter ended March 31, 2020. First Quarter 2020 Financi |
|
| June 12, 2020 |
EX-4.44 7 moho-ex44467.htm EX-4.44 Exhibit 4.44 Contract No.: EC20191112-4 Loan Agreement Party A (Lender): Techlong International Investments Limited Party B (Borrower): ECMOHO Limited Party C (Guarantor): Zeng Qingchun ID Card No.: *** Under the principles of equality, free will and good faith, and through amicable consultation, Party A, Party B and Party C have reached this Agreement and warran |
|
| June 12, 2020 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zoe Wang, certify that: 1. I have reviewed this annual report on Form 20-F of ECMOHO Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the |
|
| June 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| June 12, 2020 |
Exhibit 4.40 [THE ATTACHMENTS TO THIS EXHIBIT REFERENCED IN ARTICLE 15.2, AS BRACKETED BELOW, ARE NOT INCLUDED IN THIS EXHIBIT, AS SUCH ATTACHMENTS WERE NOT INCLUDED IN THE FINAL EXECUTED DOCUMENT.] Equity Transfer Agreement Party A1 (Transferor): Yiling (Shanghai) Information Technology Co., Ltd. Unified social credit code: 91310000MA1GC5HY9T Domicile: Room 2009, Building 2, 588 Zixing Road, Minh |
|
| June 12, 2020 |
Exhibit 13.2 ECMOHO Limited Certification Pursuant to 18 U.S.C. § 1350, the undersigned, Richard Wei, Chief Financial Officer of ECMOHO Limited (the “Company”), hereby certifies, to his knowledge, that the Company’s annual report on Form 20-F for the year ended December 31, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange |
|
| June 12, 2020 |
EX-4.46 9 moho-ex44669.htm EX-4.46 Exhibit 4.46 Supplementary Loan Agreement II Party A (Lender): Techlong International Investment Limited Party B (Borrower): Ecmoho (Hong Kong) Limited Party C (Pledgor): Uhealth Limited Party D (Guarantor): Zeng Qingchun Whereas, Party A and Party B executed two Loan Agreements in September 2017 and March 2018 respectively, and executed the Supplementary Agreeme |
|
| June 12, 2020 |
Exhibit 4.41 Agreement on Contract Cancellation This Agreement on Contract Cancellation (hereinafter referred to as "this Agreement") was signed and entered into by the following parties in Shanghai on April 27, 2020 and came into force as of such date: 1. Xianggui (Shanghai) Biotechnology Co., Ltd., with the registered address located at Room 02, F/10, Building 2, No. 588, Zixing Road, Minhang Di |
|
| June 12, 2020 |
Exhibit 4.42 Yang Infinity (Shanghai) Biotechnology Co., Limited Agreement on Cancellation of Equity Pledge Contract This Agreement on Cancellation of Equity Pledge Contract (hereinafter referred to as "this Agreement") was signed and entered into by the following parties in Shanghai on April 27, 2020 and shall come into force as of such date: Pledgee: Xianggui (Shanghai) Biotechnology Co., Ltd., |
|
| June 12, 2020 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Richard Wei, certify that: 1. I have reviewed this annual report on Form 20-F of ECMOHO Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of t |
|
| June 12, 2020 |
Exhibit 13.1 ECMOHO Limited Certification Pursuant to 18 U.S.C. § 1350, the undersigned, Zoe Wang, Chairman & Chief Executive Officer of ECMOHO Limited (the “Company”), hereby certifies, to her knowledge, that the Company’s annual report on Form 20-F for the year ended December 31, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities |
|
| June 12, 2020 |
Consent of PricewaterhouseCoopers Zhong Tian LLP Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S‑8 (No. 333-236027) of ECMOHO Limited of our report dated June 12, 2020 relating to the financial statements, which appears in this Form 20‑F. /s/PricewaterhouseCoopers Zhong Tian LLP Shanghai, the People’s Republic of China June 12, 2020 |
|
| June 12, 2020 |
EX-4.43 6 moho-ex44366.htm EX-4.43 Exhibit 4.43 Yang Infinity (Shanghai) Biotechnology Co., Limited Agreement on Cancellation of Equity Pledge Contract This Agreement on Cancellation of Equity Pledge Contract (hereinafter referred to as "this Agreement") was signed and entered into by the following parties in Shanghai on April 27, 2020 and shall come into force as of such date: Pledgee: Xianggui ( |
|
| June 12, 2020 |
EX-4.45 8 moho-ex44568.htm EX-4.45 Exhibit 4.45 Supplementary Loan Agreement Party A (Lender): Techlong International Investment Limited Party B (Borrower): ECMOHO Limited Party C (Pledgor): Uhealth Limited Party D (Guarantor): Zeng Qingchun Whereas, Party A and ECMOHO Limited executed two Loan Contracts (hereinafter collectively referred to as the "Original Loan Contracts") on November 12, 2019, |
|
| June 12, 2020 |
Description of securities registered under Section 12 of the Securities Exchange Act, as amended Exhibit 2.4 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (the “Exchange Act”) American Depositary Shares (“ADSs”), each representing four Class A ordinary shares of ECMOHO Limited (the “company,” “we” or “our”) are listed and traded on the Nasdaq Global Market under the symbol “MOHO” and, in connection with that listing (but not for tradi |
|
| May 26, 2020 |
MOHO / ECMOHO Limited / CID Greater China Fund V, LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ECMOHO Limited (Name of the Issuer) Class A Ordinary Shares, par value US$0.00001 per share American Depository Shares each representing Four Class A Ordinary Shares (Title of Class of Securities) 27888P104 (CUSIP Number) May 12, 2020 (Date of Event Whic |
|
| May 13, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic of C |
|
| May 13, 2020 |
EXHIBIT 99.1 ECMOHO Hosts Smart Health Summit with Partners to Explore New Opportunities Post Coronavirus Pandemic SHANGHAI, China, May 12, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) ("ECMOHO" or the "Company"), a leading integrated solutions provider in the rapidly growing non-medical health and wellness market in China, hosted a summit in Shanghai on May 11 on the theme of “Smart Heal |
|
| April 30, 2020 |
ECMOHO Collaborates with Gold HongYe Paper Group on Digital Strategy EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 ECMOHO Collaborates with Gold HongYe Paper Group on Digital Strategy SHANGHAI, China, April 29, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited (“ECMOHO” or the “Company”; Nasdaq: MOHO), a leading integrated solution provider in the rapidly growing non-medical health and wellness market in China, entered into strategic collaboration with Gold HongYe Paper Gro |
|
| April 30, 2020 |
Timing of Filing of Annual Report on Form 20-F for the Year ended December 31, 2019 EXHIBIT 99.2 Timing of Filing of Annual Report on Form 20-F for the Year ended December 31, 2019 SHANGHAI, China, April 29, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”) is relying on the order issued by the U.S. Securities and Exchange Commission (the “Commission”) on March 25, 2020, providing conditional relief to registrants subject to the reporting requireme |
|
| April 30, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic of |
|
| April 21, 2020 |
MOHO / ECMOHO Limited 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic of |
|
| April 21, 2020 |
ECMOHO and L&P Cosmetic Formed a Comprehensive Strategic Partnership EXHIBIT 99.1 ECMOHO and L&P Cosmetic Formed a Comprehensive Strategic Partnership SHANGHAI, China, April 20, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited (“ECMOHO” or the “Company”; Nasdaq: MOHO), a leading integrated solution provider in the rapidly growing non-medical health and wellness market in China, and L&P Cosmetic Co., Limited (“L&P Cosmetic”), a Korean cosmeceutical company, whose brands inclu |
|
| March 31, 2020 |
EXHIBIT 99.1 CORRECTION: ECMOHO Announces Fourth Quarter 2019 and Full Year 2019 Preliminary Unaudited Selected Financial Data SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) - In a release issued under the same headline on Monday, March 30th by ECMOHO Limited (Nasdaq: MOHO), please note that in the 7th bullet of the 2019 Full-Year Preliminary Unaudited Selected Financial Data, the Basic and dilu |
|
| March 31, 2020 |
MOHO / ECMOHO Limited 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic of |
|
| March 30, 2020 |
MOHO / ECMOHO Limited 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic of |
|
| March 30, 2020 |
ECMOHO and China Resources Ng Fung Enter into Strategic Partnership in the Sale of High Quality Food EXHIBIT 99.1 ECMOHO and China Resources Ng Fung Enter into Strategic Partnership in the Sale of High Quality Food SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited ("ECMOHO" or the "Company"; Nasdaq: MOHO) and China Resources Ng Fung, a member of the China Resources Group, have entered into a strategic partnership to introduce high quality food products to Chinese consumers. Under |
|
| March 12, 2020 |
ECMOHO Cooperates with Beingmate on Digital Marketing EXHIBIT 99.1 ECMOHO Cooperates with Beingmate on Digital Marketing SHANGHAI, China, March 12, 2020 (GLOBE NEWSWIRE) - ECMOHO Limited ("ECMOHO" or the "Company"; Nasdaq: MOHO) and Beingmate Baby & Child Food Co., Ltd. (“Beingmate”) entered into strategic cooperation under which ECMOHO will provide online and offline digital marketing services for three of Beingmate’s product lines, including baby f |
|
| March 12, 2020 |
MOHO / ECMOHO Limited 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic of |
|
| March 9, 2020 |
MOHO / ECMOHO Limited / CID Greater China Fund V, LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ECMOHO Limited (Name of the Issuer) Class A Ordinary Shares, par value US$0.00001 per share American Depository Shares each representing Four Class A Ordinary Shares (Title of Class of Securities) 27888P104 (CUSIP Number) November 12, 2019 (Date of Event |
|
| March 9, 2020 |
EX-99.1 2 exhibit99-1.htm Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with |
|
| March 6, 2020 |
MOHO / ECMOHO Limited / CID Greater China Fund V, LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ECMOHO Limited (Name of the Issuer) Class A Ordinary Shares, par value US$0.00001 per share American Depository Shares each representing Four Class A Ordinary Shares (Title of Class of Securities) 27888P104 (CUSIP Number) November 12, 2019 (Date of Event |
|
| March 6, 2020 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary s |
|
| February 27, 2020 |
EX-99.(A) Exhibit A JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the |
|
| February 27, 2020 |
EX-99.A 2 d884660dex99a.htm EX-99.(A) Exhibit A JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of |
|
| February 27, 2020 |
EX-99.A 2 d886639dex99a.htm EX-99.(A) Exhibit A JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of |
|
| February 27, 2020 |
MOHO / ECMOHO Limited / Liberal Rich Ltd - SCHEDULE 13G Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ECMOHO Limited (Name of Issuer) Class A ordinary shares, par value $0.00001 per share (Title of Class of Securities) G29213 108 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box |
|
| February 27, 2020 |
MOHO / ECMOHO Limited / Behealth Ltd - SCHEDULE 13G Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ECMOHO Limited (Name of Issuer) Class A ordinary shares, par value $0.00001 per share (Title of Class of Securities) G29213 108 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box |
|
| February 27, 2020 |
MOHO / ECMOHO Limited / Uhealth Ltd - SCHEDULE 13G Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ECMOHO Limited (Name of Issuer) Class A ordinary shares, par value $0.00001 per share (Title of Class of Securities) G29213 108 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box |
|
| February 24, 2020 |
MOHO / ECMOHO Limited / Smart Warrior Ltd - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ECMOHO Limited (Name of Issuer) Class A Ordinary Shares, par value US$0.00001 per share (Title of Class of Securities) 27888P 104 (1) (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des |
|
| February 24, 2020 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree (i) to the joint filing, on behalf of each of them, of a statement on Schedule 13G (including amendments thereto) with respect to Class A ordinary shares, par value US$0.00001 per share of ECMOHO Limited, a Cayman Islands company; a |
|
| January 23, 2020 |
MOHO / ECMOHO Limited S-8 - - FORM S-8 Form S-8 As filed with the Securities and Exchange Commission on January 23, 2020 Registration No. |
|
| January 9, 2020 |
EXHIBIT 99.1 ECMOHO CEO Delivered a Speech about How Technology Helps Accomplish High Growth of the Mother and Childcare Products Industry at the 2019 China Mother and Child Entrepreneurs Summit SHANGHAI, China, Jan. 09, 2020 (GLOBE NEWSWIRE) - Ms. Zoe Wang, Founder and Chief Executive Officer of ECMOHO Limited ("ECMOHO" or the "Company"; Nasdaq: MOHO), a leading integrated solutions provider in t |
|
| January 9, 2020 |
MOHO / ECMOHO Limited 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2020 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant's name into English) 3F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic |
|
| November 26, 2019 |
MOHO / ECMOHO Limited 6-K - Current Report of Foreign Issuer - FORM 6-K Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the Month of November, 2019 Commission File Number: 001-39121 ECMOHO Limited (Translation of registrant’s name into English) 3F, 1000 Tianyaoqiao Road Xuhui District Shanghai, 200030 The People’s Republic of China |
|
| November 26, 2019 |
ECMOHO Announces Third Quarter 2019 Unaudited Financial Results EX-99.1 2 d837691dex991.htm EX-99.1 Exhibit 99.1 ECMOHO Announces Third Quarter 2019 Unaudited Financial Results SHANGHAI, CHINA – Nov. 25, 2019 (GLOBE NEWSWIRE) – ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the rapidly growing non-medical health and wellness market in China, today announced its unaudited financial results for the third qua |
|
| November 12, 2019 |
4,375,000 American Depositary Shares ECMOHO Limited Representing 17,500,000 Class A Ordinary Shares 424(B)(4) Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-233951 4,375,000 American Depositary Shares ECMOHO Limited Representing 17,500,000 Class A Ordinary Shares This is an initial public offering of American depositary shares, or ADSs, of ECMOHO Limited. ECMOHO Limited is offering 4,375,000 ADSs to be sold in the offering. Each ADS represents four Class A ordinary share |
|
| November 7, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A/A Amendment No. 1 to Form 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ECMOHO Limited (Exact name of registrant as specified in its charter) Cayman Islands Not applicable (State or other jurisdiction of incorporation or organization) (I |
|
| November 7, 2019 |
As filed with the Securities and Exchange Commission on November 7, 2019 Table of Contents As filed with the Securities and Exchange Commission on November 7, 2019 Registration No. |
|
| November 7, 2019 |
Free Writing Prospectus Filed pursuant to Rule 433 Registration No. 333-233951 November 7, 2019 ECMOHO Limited has filed a registration statement on Form F-1, including a prospectus, with the Securities and Exchange Commission, or the SEC, for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus in that registration statement and other docum |
|
| November 7, 2019 |
MOHO / ECMOHO Limited CORRESP - - CORRESP November 7, 2019 Via EDGAR CONFIDENTIAL U.S. Securities and Exchange Commission, Division of Corporate Finance, Office of Consumer Products, 100 F Street, N.E., Washington, D.C. 20549. Attention: Yolanda Guobadia Donna Di Silvio Jennifer Lopez-Molina Mara Ransom Re: ECMOHO Limited Amendment No. 2 to Registration Statement on Form F-1 Filed November 6, 2019 File Number: 333-233951 Ladies an |
|
| November 6, 2019 |
MOHO / ECMOHO Limited CORRESP - - Issuer Acceleration letter ECMOHO Limited 3/F, No. 1000 Tianyaoqiao Road, Xuhui District, Shanghai, 200030, The People’s Republic of China November 6, 2019 U.S. Securities and Exchange Commission, Division of Corporate Finance, Office of Consumer Products, 100 F Street, N.E., Washington, D.C. 20549. Attention: Yolanda Guobadia Donna Di Silvio Jennifer Lopez-Molina Mara Ransom Re: ECMOHO Limited Re |
|
| November 6, 2019 |
Free Writing Prospectus Filed pursuant to Rule 433 Registration No. 333-233951 November 6, 2019 ECMOHO Limited has filed a registration statement on Form F-1, including a prospectus, with the Securities and Exchange Commission, or the SEC, for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus in that registration statement and other docum |
|
| November 6, 2019 |
As filed with the Securities and Exchange Commission on November 6, 2019 Table of Contents As filed with the Securities and Exchange Commission on November 6, 2019 Registration No. |
|
| November 6, 2019 |
MOHO / ECMOHO Limited CORRESP - - November 6, 2019 Via EDGAR Securities and Exchange Commission 100 F Street, N.W. Washington, D.C. 20549 Attention: Corey Jennings, Esq. Office of International Corporate Finance Division of Corporate Finance Re: ECMOHO Limited Registration Statement on Form F-6 (Registration No.: 333-234148) Dear Mr. Jennings: Citibank N.A., as depositary (the “Depositary”) and acting solely on behalf of the legal |
|
| November 6, 2019 |
MOHO / ECMOHO Limited CORRESP - - CORRESP November 6, 2019 Via EDGAR CONFIDENTIAL U.S. Securities and Exchange Commission, Division of Corporate Finance, Office of Consumer Products, 100 F Street, N.E., Washington, D.C. 20549. Attention: Yolanda Guobadia Donna Di Silvio Jennifer Lopez-Molina Mara Ransom Re: ECMOHO Limited Amendment No. 1 to Registration Statement on Form F-1 Filed November 1, 2019 File Number: 333-233951 Ladies an |
|
| November 6, 2019 |
MOHO / ECMOHO Limited CORRESP - - Underwriters Acceleration Letter UBS Securities LLC 1285 Avenue Of The Americas New York, NY 10019 United States of America China International Capital Corporation Hong Kong Securities Limited 29th Floor, One International Finance Centre 1 Harbour View Street Central, Hong Kong AMTD Global Markets Limited 23/F-25/F Nexxus Building 41 Connaught Road Central Hong Kong Needham & Company, LLC 250 Park Avenue 10th Floor New York, NY 10177 Tiger Brokers (NZ) Limited Level 4, 142 Broadway Newmarket, Auckland 1023 New Zealand As representatives of the several underwriters November 6, 2019 VIA EDGAR Yolanda Guobadia Donna Di Silvio Jennifer Lopez-Molina Mara Ransom U. |
|
| November 1, 2019 |
As filed with the Securities and Exchange Commission on November 1, 2019 Registration No. |
|
| November 1, 2019 |
DEPOSIT AGREEMENT by and among ECMOHO LIMITED and CITIBANK, N.A., as Depositary, and THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES ISSUED HEREUNDER Dated as of [date], 2019 TABLE OF CONTENTS Article I DEFINITIONS 1 Section 1.1 “ADS Record Date” 1 Section 1.2 “Affiliate” 1 Section 1.3 “American Depositary Receipt(s)”, “ADR(s)” and “Receipt(s)” 1 Section 1.4 “American Depositary Sh |
|
| November 1, 2019 |
Form of Underwriting Agreement Exhibit 1.1 [?] CLASS A ORDINARY SHARES ECMOHO LIMITED CLASS A ORDINARY SHARES, PAR VALUE US$0.00001 PER SHARE IN THE FORM OF AMERICAN DEPOSITARY SHARES UNDERWRITING AGREEMENT [?], 2019 [UBS Securities LLC 1285 Avenue Of The Americas New York, NY 10019 United States of America China International Capital Corporation Hong Kong Securities Limited 29th Floor, One International Finance Centre 1 Harbou |
|
| November 1, 2019 |
MOHO / ECMOHO Limited CORRESP - - CORRESPONDENCE November 1, 2019 Via EDGAR CONFIDENTIAL U.S. Securities and Exchange Commission, Division of Corporate Finance, Office of Consumer Products, 100 F Street, N.E., Washington, D.C. 20549. Attention: Yolanda Guobadia Donna Di Silvio Jennifer Lopez-Molina Mara Ransom Re: ECMOHO Limited Amendment No. 1 to Registration Statement on Form F-1 Filed September 26, 2019 File Number: 333-233951 |
|
| November 1, 2019 |
As filed with the Securities and Exchange Commission on November 1, 2019 Table of Contents As filed with the Securities and Exchange Commission on November 1, 2019 Registration No. |
|
| November 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ECMOHO Limited (Exact name of registrant as specified in its charter) Cayman Islands Not applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification |
|
| October 10, 2019 |
As filed with the Securities and Exchange Commission on October 10, 2019 Registration No. |
|
| October 10, 2019 |
Exhibit (d) October 10, 2019 Citibank, N.A. – ADR Department 388 Greenwich Street New York, New York 10013 Ladies and Gentlemen: We refer to the Registration Statement on Form F-6 (the “Registration Statement”) to be filed with the Securities and Exchange Commission (the “SEC”) by the legal entity to be created by the Deposit Agreement (as hereinafter defined) for the purpose of registering under |
|
| October 10, 2019 |
Exhibit (a) DEPOSIT AGREEMENT by and among ECMOHO LIMITED and CITIBANK, N.A., as Depositary, and THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES ISSUED HEREUNDER Dated as of [date], 2019 TABLE OF CONTENTS Article I DEFINITIONS 1 Section 1.1 “ADS Record Date” 1 Section 1.2 “Affiliate” 1 Section 1.3 “American Depositary Receipt(s)”, “ADR(s)” and “Receipt(s)” 1 Section 1.4 “American D |
|
| September 26, 2019 |
Memorandum and Articles of Association of the Registrant, currently in effect. EX-3.1 2 d637426dex31.htm EX-3.1 Exhibit 3.1 THE COMPANIES LAW (AS AMENDED) COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION OF ECMOHO LIMITED (ADOPTED BY A SPECIAL RESOLUTION OF SHAREHOLDERS DATED NOVEMBER 23, 2018) REF: YX/SSNC/E2208-H17292 THE COMPANIES LAW (AS AMENDED) COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM OF |
|
| September 26, 2019 |
Exhibit 99.2 ?????????1515?????????10 ? 200040 10/F, Tower 1, Jing An Kerry Centre, 1515 West Nanjing Road, Shanghai 200040, China ?? Tel: +86 21 6019 2600 ?? Fax: +86 21 6019 2697 ?? Email: [email protected] ?? Web: www.tongshang.com LEGAL OPINION To: ECMOHO Limited 3F, 1000 Tianyaoqiao Road, Xuhui District Shanghai, 200030 People?s Republic of China September 26, 2019 Dear Sirs: 1. We are l |
|
| September 26, 2019 |
EX-10.13 18 d637426dex1013.htm EX-10.13 Exhibit 10.13 PREFERRED SHARE PURCHASE AGREEMENT by and between ECMOHO LIMITED, ECMOHO (HONG KONG) HEALTH TECHNOLOGY LIMITED, SHANGHAI ECMOHO HEALTH BIOTECHNOLOGY CO., LTD., WANG YING, ZENG QINGCHUN, and EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO Dated as of August 2, 2018 TABLE OF CONTENTS Page ARTICLE I PURCHASE AND SALE OF PREFERRED SHARES 1.1 Sale |
|
| September 26, 2019 |
Exhibit 10.16 JOINDER AGREEMENT This joinder agreement (this ?Joinder Agreement?) is made as of the date written below by the undersigned (the ?Additional Purchaser?) in accordance with Section 1.3 of that certain Preferred Share Purchase Agreement, dated as of August 2, 2018 (the ?SPA?), by and between ECMOHO Limited (the ?Company?) and each of the investors listed on Exhibit A thereto (the ?Purc |
|
| September 26, 2019 |
Exhibit 10.19 CONFIDENTIAL ECMOHO 2018 OMNIBUS INCENTIVE PLAN ARTICLE 1 GENERAL 1.1 Purpose The purpose of the Ecmoho 2018 Omnibus Incentive Plan (the ?Plan?) is to promote the success and enhance the value of Ecmoho, a company formed under the laws of the Cayman Islands (the ?Company?), by linking the personal interests of the Directors, Employees and Consultants to those of the Company?s shareho |
|
| September 26, 2019 |
Exhibit 10.30 Online Self-service Loan Business Contract of Ping An Bank 1 Online Self-service Loan Business Contract of Ping An Bank Contract No.: P. Y. (Shanghai) Z. Y. D. Z. No.A454201806140001 ?under the non-comprehensive credit line (under the single credit line) ?Under the comprehensive credit line- Name of the contract: Comprehensive Credit Line Contract Contract No.: P. Y. (Shanghai) Z. Z. |
|
| September 26, 2019 |
Exhibit 10.32 Contract No.: 1809-069382502-01 Comprehensive Credit Line Contract Contract version number: FB201701 (applicable for companies) The Contract was signed by the following parties on September 25, 2018 in Pudong New Area, Shanghai: Applicant: Shanghai Tonggou Information Technology Co., Ltd. Domicile (Address): Room 302, 3/F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai Legal represe |
|
| September 26, 2019 |
Exhibit 99.1 ECMOHO LIMITED Code of Business Conduct and Ethics Adopted on September 24, 2019 Introduction This Code of Business Conduct and Ethics (the ?Code?) has been adopted by our Board of Directors and summarizes the standards that must guide our actions. Although they cover a wide range of business practices and procedures, these standards cannot and do not cover every issue that may arise, |
|
| September 26, 2019 |
EX-10.36 41 d637426dex1036.htm EX-10.36 Exhibit 10.36 NINGBO COMMERCE BANK Comprehensive Credit Line Contract Ningbo Commerce Bank (201812 Version) Comprehensive Credit Line Contract (Standard Terms) Detailed information of Party A and Party B may be found in the subsidiary terms. On the basis of equality and voluntariness, Party A and Party B have concluded the Contract upon consensus in accordan |
|
| September 26, 2019 |
Exhibit 10.28 EXECUTION VERSION Dated the 23rd day of November 2018 BEHEALTH LIMITED (as the ?Chargor ?) and TAIPEI FUBON COMMERCIAL BANK CO., LTD., HONG KONG BRANCH (as the ?Chargee?) SHARE CHARGE in respect of 9,393,800 Class B Ordinary Shares of the Entire Issued Share Capital of ECMOHO LIMITED Li, Wong, Lam & W.I. Cheung Solicitors 22/F., Infinitus Plaza, 199 Des Voeux Road Central, Hong Kong |
|
| September 26, 2019 |
Exhibit 10.17 SHARE SUBSCRIPTION AGREEMENT between ECMOHO LIMITED, and EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO Dated as of August 7, 2018 TABLE OF CONTENTS Page ARTICLE I SUBSCRIPTION OF SHARES 1.1 Subscription of Shares 1 1.2 Closing; Delivery 1 1.3 Defined Terms Used in this Agreement 1 ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE COMPANY 2.1 Organization, Good Standing, Corporate P |
|
| September 26, 2019 |
Exhibit 10.12 Spousal Consent Letter Whereas: 1. I, Ying Wang, a Chinese citizen with the ID number of ***, is the spouse of Qingchun Zeng, who is the shareholder of Yang Infinity (Shanghai) Biotechnology Co., Limited ; 1. Qingchun Zeng, Xianggui (Shanghai) Biotechnology Co., Ltd. and Yang Infinity (Shanghai) Biotechnology Co., Limited have entered into a series of agreements and any exhibits and |
|
| September 26, 2019 |
Exhibit 10.14 JOINDER AGREEMENT This joinder agreement (this ?Joinder Agreement?) is made as of the date written below by the undersigned (the ?Additional Purchaser?) in accordance with Section 1.3 of that certain Preferred Share Purchase Agreement, dated as of August 2, 2018 (the ?SPA?), by and between ECMOHO Limited (the ?Company?) and each of the investors listed on Exhibit A thereto (the ?Purc |
|
| September 26, 2019 |
EX-10.22 27 d637426dex1022.htm EX-10.22 Exhibit 10.22 Share Transfer Agreement The Share Transfer Agreement (the “Agreement”) was concluded by and among the following parties on June 25, 2019 (the “Signing Date”): (1) Suzhou Dadehongqiang Investment Center (Limited Partnership), a limited partnership established under the laws of China and subsisting lawfully, with a residence of Room 306, Dasen B |
|
| September 26, 2019 |
Exhibit 10.23 Share Transfer Agreement The Share Transfer Agreement (the ?Agreement?) was concluded by and among the following parties on June 25, 2019 (the ?Signing Date?): (1) Beijing Tianrundiliang Investment Co., Ltd., a company with limited liability established under the laws of China and subsisting lawfully, with a residence of No.1-S47, Area 1, Guba Road, Chengguan Sub-district, Fangshan D |
|
| September 26, 2019 |
Exhibit 10.31 Confidential To Shanghai Tong Gou Information Technology Co., Ltd., Company address: Room 302, 3/F, Tianyaoqiao Road, Xuhui District, Shanghai, China Addressee: Li Wei Date: November 15, 2018 Dear Sir / Madam, Bank credit granting (Letter of credit granting No.: CN11095026159-181011) On the basis of the recent discussions with you, the Bank hereby confirms that it agrees to grant you |
|
| September 26, 2019 |
Exhibit 10.34 Loan Agreement Party A (Lender): Shanghai Focus Brand Management Co., Ltd. Address: 17/F, 558 East Daming Road Tel.: 021-63055858 Party B (Borrower): Shanghai ECMOHO Health Biotechnology Co., Ltd. Address: 3/F, No.1000 Tianyaoqiao Road Tel.: 64172213 Party C (Guarantor): Wang Ying ID No.: **** Domicile: **** Tel.: **** Party A and Party B hereby agree as follows upon negotiations in |
|
| September 26, 2019 |
Exhibit 10.35 2018 version China Merchants Bank Co., Ltd. Shanghai Branch Credit Agreement (Applicable to the case where no loan contract is separately signed for the working capital loan) 1 Credit Agreement (Applicable to the case where no loan contract is separately signed for the working capital loan) No.: 9602190301 Creditor: China Merchants Bank Co., Ltd. Shanghai Tianyaoqiao Sub-branch (here |
|
| September 26, 2019 |
EX-10.38 43 d637426dex1038.htm EX-10.38 Exhibit 10.38 COMMERCIAL BANKING (CARM 180910) CONFIDENTIAL The Directors Ecmoho (Hong Kong) Limited Shang Hai Shi Xu Hui Qu Tian Yue Qiao Lu 1000 Hao 3 Lou Xu Hui Yuan Shang Wu Lou China 29 October 2018 Dear Sirs BANKING FACILITIES With reference to our recent discussions, we are pleased to confirm our agreement to granting you the following facilities. The |
|
| September 26, 2019 |
Exhibit 21.1 ECMOHO Limited List of Significant Subsidiaries 1. ECMOHO (Hong Kong) Health Technology Limited Hong Kong 2. ECMOHO (Hong Kong) Limited Hong Kong 3. ECMOHO Co., Ltd. Japan 4. ECMOHO Co., Ltd. Korea 5. Shanghai ECMOHO Health Biotechnology Co, Ltd. PRC 6. Yiling (Shanghai) Information Technology Co., Ltd. PRC 7. Import - It Corp. BVI 8. Yipinda (Shanghai) Health Technology Co., Ltd. PRC |
|
| September 26, 2019 |
EX-10.4 9 d637426dex104.htm EX-10.4 Exhibit 10.4 Power of Attorney I, Ying Wang, citizen of the People’s Republic of China (the “PRC”) with the identification number of ***, is the shareholder of Shanghai Yibo Medical Devices Co., Ltd. (“Shanghai Yibo”) who holds 50% of the equity interest of Shanghai Yibo (“My Equity Interest”). Regarding My Equity Interest, I hereby unconditionally and irrevocab |
|
| September 26, 2019 |
EX-10.24 29 d637426dex1024.htm EX-10.24 Exhibit 10.24 Credit Granting Approval Notice Date: October 18, 2018 (181018-TFB01252514) To: ECMOHO (Hong Kong) Limited Import It Corp. (the “Client”) Dear Client, Taipei Fubon Commercial Bank Co., Ltd. Hong Kong Branch (the “Bank”) will provide or extend the following line of credit (the “Credit Granting”) according to the following conditions and the Gene |
|
| September 26, 2019 |
Exhibit 10.2 Equity Interest Pledge Agreement This Equity Interest Pledge Agreement (this ?Agreement?) is executed by and among the following parties on November 28, 2018: Pledgee: Shanghai ECMOHO Health Biotechnology Co, Ltd. Registered Address: Floor 2&3, No. 1000 Tianyaoqiao Road, Xuhui District, Shanghai Pledgors: Ying Wang (Chinese ID No.: ***) Qingchun Zeng (Chinese ID No.: ***) Whereas: 1. |
|
| September 26, 2019 |
EX-10.15 20 d637426dex1015.htm EX-10.15 Exhibit 10.15 JOINDER AGREEMENT This joinder agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned (the “Additional Purchaser”) in accordance with Section 1.3 of that certain Preferred Share Purchase Agreement, dated as of August 2, 2018 (the “SPA”), by and between ECMOHO Limited (the “Company”) and each of the investor |
|
| September 26, 2019 |
EX-10.11 16 d637426dex1011.htm EX-10.11 Exhibit 10.11 Confirmation Letter Whereas: 1. I, Zeng Qingchun, a citizen of the People’s Republic of China, whose ID card number is ***, am a shareholder who owns 50% equity (“my equity”) in Yang infinity (Shanghai) Biotechnology Co., Limited; 2. I, Xianggui (Shanghai) Biotechnology Co., Ltd. and Yang infinity (Shanghai) Biotechnology Co., Limited have conc |
|
| September 26, 2019 |
EX-10.10 15 d637426dex1010.htm EX-10.10 Exhibit 10.10 Power of Attorney I, Ying Wang, citizen of the People’s Republic of China (the “PRC”) with the identification number of ***, is the shareholder of Yang Infinity (Shanghai) Biotechnology Co., Limited (“Yang Infinity”) who holds 50% of the equity interest of Yang Infinity (“My Equity Interest”). Regarding My Equity Interest, I hereby unconditiona |
|
| September 26, 2019 |
Exhibit 10.20 Share Transfer Agreement The Share Transfer Agreement (the ?Agreement?) was entered into by and among the following parties in Shanghai on [July] [26], 2018. Transferors: (1) Shanghai Yiheng Industrial Co., Ltd., a limited liability company established under the laws of China, with a residence of Room 148, Area A, Building 2, No.420 Fenglin Road, Xuhui District, Shanghai; (2) Wang Yi |
|
| September 26, 2019 |
Exhibit 10.25 Execution Version THIS DEED OF CHARGE OF INVENTORIES is made on 23 November 2018 BETWEEN (1) Import It Corp., a company incorporated under the laws of the British Virgin Islands whose registered office is situated at Intershore Consult (BVI) Limited of Intershore Chamber, Wickham Cay 1, P.O. Box 4342, Road Town, Tortola, British Virgin Islands (?the Company?); and (2) Taipei Fubon Co |
|
| September 26, 2019 |
Exhibit 10.7 Exclusive Technology Consulting and Service Agreement This Exclusive Technology Consulting and Service Agreement (hereinafter referred to as the ?Agreement?) is entered into between the following parties on June 21, 2019: Party A: Xianggui (Shanghai) Biotechnology Co., Ltd. Registration No.: 91310112MA1GC6PG5T Registered Address: Room 02, 10/F, Building 2, No.588 Zixing Road, Minhang |
|
| September 26, 2019 |
Exhibit 10.27 Execution Version Dated 23 November 2018 IMPORT IT CORP. as Chargor and TAIPEI FUBON COMMERCIAL BANK CO., LTD. HONG KONG BRANCH as Chargee CHARGE OVER BANK ACCOUNT Table of Contents 1 Definitions and interpretation 1 2 Covenant to pay 6 3 Charges and Assignments 6 4 Set-off 7 5 Restrictions 7 6 Perfection 7 7 Enforcement 8 8 Application of proceeds 12 9 Representations and warranties |
|
| September 26, 2019 |
Exhibit 10.3 EXCLUSIVE CALL OPTION AGREEMENT This Exclusive Call Option Agreement (this ?Agreement?) is executed by and among the following parties on November 28, 2018: 1. Shanghai ECMOHO Health Biotechnology Co, Ltd., a limited liability company duly registered in PRC, with its address at Floor 2&3, No. 1000 Tianyaoqiao Road, Xuhui District, Shanghai (?Party A?); 2. Ying Wang, with Chinese ident |
|
| September 26, 2019 |
EX-10.5 10 d637426dex105.htm EX-10.5 Exhibit 10.5 Confirmation Letter Whereas: 1. I, Zeng Qingchun, a citizen of the People’s Republic of China, whose ID card number is ***, am a shareholder who owns 50% equity (“my equity”) in Shanghai Yibo Medical Devices Co., Ltd.; 2. I, Shanghai ECMOHO Health Biotechnology Co., Ltd. and Shanghai Yibo Medical Devices Co., Ltd. have concluded a series of agreeme |
|
| September 26, 2019 |
Exhibit 10.1 Exclusive Technology Consulting and Service Agreement This Exclusive Technology Consulting and Service Agreement (hereinafter referred to as the ?Agreement?) is entered into between the following parties on November 28, 2018: Party A: Shanghai ECMOHO Health Biotechnology Co, Ltd. Registration No.: 913100005886672355 Registered Address: Floor 2&3, No. 1000 Tianyaoqiao Road, Xuhui Distr |
|
| September 26, 2019 |
Exhibit 10.18 INVESTORS RIGHTS AGREEMENT by and among ECMOHO LIMITED, BEHEALTH LIMITED, UHEALTH LIMITED, ECMOHO (HONG KONG) HEALTH TECHNOLOGY LIMITED, SHANGHAI ECMOHO HEALTH BIOTECHNOLOGY CO., LTD., WANG YING, ZENG QINGCHUN and EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO Dated as of August 7, 2018 TABLE OF CONTENTS Page ARTICLE I. INTRODUCTORY MATTERS 1.1 Defined Terms 2 1.2 Interpretation; C |
|
| September 26, 2019 |
Exhibit 10.21 Share Transfer Agreement The Share Transfer Agreement (the ?Agreement?) was concluded by and among the following parties on June 25, 2019 (the ?Signing Date?): (1) Ningbo Yuanyuan Liuchang Investment Center (Limited Partnership), a limited partnership established under the laws of China and subsisting lawfully, with a residence of H1237, Area A, Room 401, Block 1, No.88 Qixing Road, |
|
| September 26, 2019 |
Powers of Attorney (included on signature page) Table of Contents As filed with the Securities and Exchange Commission on September 26, 2019 Registration No. |
|
| September 26, 2019 |
Exhibit 10.39 FORM OF INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this ?Agreement?) is made as of , 20 by and between ECMOHO Limited, an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands (the ?Company?), and (the ?Indemnitee?). WHEREAS, the Indemnitee has agreed to serve as a director or executive officer of the Company, and in suc |
|
| September 26, 2019 |
MOHO / ECMOHO Limited CORRESP - - CORRESPONDENCE September 26, 2019 Via EDGAR CONFIDENTIAL U.S. Securities and Exchange Commission, Division of Corporate Finance, Office of Consumer Products, 100 F Street, N.E., Washington, D.C. 20549. Attention: Yolanda Guobadia Donna Di Silvio Jennifer Lopez-Molina Mara Ransom Re: ECMOHO Limited Amendment No.1 to Draft Registration Statement on Form F-1 Filed August 30, 2019 CIK 0001763197 Ladie |
|
| September 26, 2019 |
Exhibit 10.26 Execution Version Dated 23 November 2018 IMPORT IT CORP. as Chargor and TAIPEI FUBON COMMERCIAL BANK, CO. LTD. HONG KONG BRANCH as Chargee CHARGE OVER RECEIVABLES Table of Contents 1 Definitions and interpretation 1 2 Covenant to pay 5 3 Charges and Assignments 5 4 Set-off 6 5 Restrictions 6 6 Perfection 7 7 Enforcement 8 8 Application of proceeds 12 9 Representations and warranties |
|
| September 26, 2019 |
Exhibit 10.29 August 2016 Version Working Capital Loan Contract Contract No.: 01611 Creditor: Industrial Bank Co., Ltd. Shanghai Xuhui Sub-branch Borrower: Shanghai ECMOHO Health Biotechnology Co., Ltd. 1 Important Notes for Signing To protect your rights and interests, please carefully read, examine and confirm the following matters before signing the Contract: I. You have the right to sign the C |
|
| September 26, 2019 |
Exhibit 10.6 Confirmation Letter Whereas: 1. I, Ying Wang, a Chinese citizen with the ID number of ***, is the spouse of Qingchun Zeng, who is the shareholder of Shanghai Yibo Medical Devices Co., Ltd.; 1. Qingchun Zeng, Shanghai ECMOHO Health Biotechnology Co, Ltd. and Shanghai Yibo Medical Devices Co., Ltd. have entered into a series of agreements and any exhibits and amendments thereto, includi |
|
| September 26, 2019 |
EX-10.8 13 d637426dex108.htm EX-10.8 Exhibit 10.8 Equity Interest Pledge Agreement This Equity Interest Pledge Agreement (this “Agreement”) is executed by and among the following parties on June 21, 2019: Pledgee: Xianggui (Shanghai) Biotechnology Co., Ltd. Registered Address: Room 02, 10/F, Building 2, No.588 Zixing Road, Minhang District, Shanghai Pledgors: Ying Wang (Chinese ID No.: ***) Qingch |
|
| September 26, 2019 |
Exhibit 4.2 au Shares Number Share Certificate ECMOHO Limited This is to certify that of is the registered holder of fully paid and non-assessable Class A Ordinary Shares of US$0.00001 each, subject to the Memorandum and Articles of the Association of the Company as amended, and transferable only on the books of the Company by the holder hereof by a duly authorized representative or by duly appoin |
|
| September 26, 2019 |
Exhibit 3.2 THE COMPANIES LAW (AS AMENDED) COMPANY LIMITED BY SHARES THIRD AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION OF ECMOHO LIMITED (ADOPTED BY A SPECIAL RESOLUTION OF SHAREHOLDERS DATED 2019 AND EFFECTIVE IMMEDIATELY PRIOR TO THE CLOSING OF THE COMPANY?S INITIAL PUBLIC OFFERING OF CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES ON THE DESIGNAT |
|
| September 26, 2019 |
Exhibit 10.9 EXCLUSIVE CALL OPTION AGREEMENT This Exclusive Call Option Agreement (this ?Agreement?) is executed by and among the following parties on June 21, 2019: 1. Xianggui (Shanghai) Biotechnology Co., Ltd., a limited liability company duly registered in PRC, with its address at Room 02, 10/F, Building 2, No.588 Zixing Road, Minhang District, Shanghai (?Party A?); 2. Ying Wang, with Chinese |
|
| September 26, 2019 |
Exhibit 10.37 Loan Agreement Party A (Lender): TECHLONG INTERNATIONAL INVESTMENTS LIMITED Party B (Borrower): ECMOHO (Hong Kong) Limited Party C (Guarantor): Shanghai ECMOHO Health Biotechnology Co., Ltd. Party D (Co-guarantor): Wang Ying ID No.: **** In the principle of equality, voluntariness and sincerity, Party A, Party B, Party C and Party D reach the Loan Agreement (the ?Agreement?) upon neg |
|
| September 26, 2019 |
Exhibit 10.33 2016 edition No.: 3654012018016 Comprehensive Credit Extension Agreement China Everbright Bank Contents Chapter 1 Definition and Interpretation Chapter 2 Maximum Credit Line and Specific Credit Line Chapter 3 Length of Maturity of Credit Chapter 4 Maximum Credit Line and Use of Specific Credit Line Chapter 5 Rate Chapter 6 Adjustment of Maximum Credit Line and Specific Credit Line Ch |
|
| August 30, 2019 |
As confidentially submitted to the Securities and Exchange Commission on August 30, 2019 Table of Contents As confidentially submitted to the Securities and Exchange Commission on August 30, 2019 Registration No. |
|
| August 30, 2019 |
Equity Interest Pledge Agreement Exhibit 10.8 Equity Interest Pledge Agreement This Equity Interest Pledge Agreement (this ?Agreement?) is executed by and among the following parties on June 21, 2019: Pledgee: Xianggui (Shanghai) Biotechnology Co., Ltd. Registered Address: Room 02, 10/F, Building 2, No.588 Zixing Road, Minhang District, Shanghai Pledgors: Ying Wang (Chinese ID No.: ***) Qingchun Zeng (Chinese ID No.: ***) Whereas |
|
| August 30, 2019 |
EXCLUSIVE CALL OPTION AGREEMENT Exhibit 10.9 EXCLUSIVE CALL OPTION AGREEMENT This Exclusive Call Option Agreement (this ?Agreement?) is executed by and among the following parties on June 21, 2019: 1. Xianggui (Shanghai) Biotechnology Co., Ltd., a limited liability company duly registered in PRC, with its address at Room 02, 10/F, Building 2, No.588 Zixing Road, Minhang District, Shanghai (?Party A?); 2. Ying Wang, with Chinese |
|
| August 30, 2019 |
Post-Shipment Buyer Loans Limit EX-10.38 29 filename29.htm Exhibit 10.38 COMMERCIAL BANKING (CARM 180910) CONFIDENTIAL The Directors Ecmoho (Hong Kong) Limited Shang Hai Shi Xu Hui Qu Tian Yue Qiao Lu 1000 Hao 3 Lou Xu Hui Yuan Shang Wu Lou China 29 October 2018 Dear Sirs BANKING FACILITIES With reference to our recent discussions, we are pleased to confirm our agreement to granting you the following facilities. The facilities w |
|
| August 30, 2019 |
Exhibit 10.21 Share Transfer Agreement The Share Transfer Agreement (the ?Agreement?) was concluded by and among the following parties on June 25, 2019 (the ?Signing Date?): (1) Ningbo Yuanyuan Liuchang Investment Center (Limited Partnership), a limited partnership established under the laws of China and subsisting lawfully, with a residence of H1237, Area A, Room 401, Block 1, No.88 Qixing Road, |
|
| August 30, 2019 |
EX-10.23 16 filename16.htm Exhibit 10.23 Share Transfer Agreement The Share Transfer Agreement (the “Agreement”) was concluded by and among the following parties on June 25, 2019 (the “Signing Date”): (1) Beijing Tianrundiliang Investment Co., Ltd., a company with limited liability established under the laws of China and subsisting lawfully, with a residence of No.1-S47, Area 1, Guba Road, Chenggu |
|
| August 30, 2019 |
Exclusive Technology Consulting and Service Agreement Exhibit 10.7 Exclusive Technology Consulting and Service Agreement This Exclusive Technology Consulting and Service Agreement (hereinafter referred to as the ?Agreement?) is entered into between the following parties on June 21, 2019: Party A: Xianggui (Shanghai) Biotechnology Co., Ltd. Registration No.: 91310112MA1GC6PG5T Registered Address: Room 02, 10/F, Building 2, No.588 Zixing Road, Minhang |
|
| August 30, 2019 |
Exhibit 10.13 PREFERRED SHARE PURCHASE AGREEMENT by and between ECMOHO LIMITED, ECMOHO (HONG KONG) HEALTH TECHNOLOGY LIMITED, SHANGHAI ECMOHO HEALTH BIOTECHNOLOGY CO., LTD., WANG YING, ZENG QINGCHUN, and EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO Dated as of August 2, 2018 TABLE OF CONTENTS Page ARTICLE I PURCHASE AND SALE OF PREFERRED SHARES 1.1 Sale and Issuance of Preferred Shares 1 1.2 C |
|
| August 30, 2019 |
EX-10.31 22 filename22.htm Exhibit 10.31 Confidential To Shanghai Tong Gou Information Technology Co., Ltd., Company address: Room 302, 3/F, Tianyaoqiao Road, Xuhui District, Shanghai, China Addressee: Li Wei Date: November 15, 2018 Dear Sir / Madam, Bank credit granting (Letter of credit granting No.: CN11095026159-181011) On the basis of the recent discussions with you, the Bank hereby confirms |
|
| August 30, 2019 |
EX-10.12 10 filename10.htm Exhibit 10.12 Spousal Consent Letter Whereas: 1. I, Ying Wang, a Chinese citizen with the ID number of ***, is the spouse of Qingchun Zeng, who is the shareholder of Yang Infinity (Shanghai) Biotechnology Co., Limited ; 1. Qingchun Zeng, Xianggui (Shanghai) Biotechnology Co., Ltd. and Yang Infinity (Shanghai) Biotechnology Co., Limited have entered into a series of agree |
|
| August 30, 2019 |
Comprehensive Credit Extension Agreement China Everbright Bank EX-10.33 24 filename24.htm Exhibit 10.33 2016 edition No.: 3654012018016 Comprehensive Credit Extension Agreement China Everbright Bank Contents Chapter 1 Definition and Interpretation Chapter 2 Maximum Credit Line and Specific Credit Line Chapter 3 Length of Maturity of Credit Chapter 4 Maximum Credit Line and Use of Specific Credit Line Chapter 5 Rate Chapter 6 Adjustment of Maximum Credit Line |
|
| August 30, 2019 |
EX-10.10 8 filename8.htm Exhibit 10.10 Power of Attorney I, Ying Wang, citizen of the People’s Republic of China (the “PRC”) with the identification number of ***, is the shareholder of Yang Infinity (Shanghai) Biotechnology Co., Limited (“Yang Infinity”) who holds 50% of the equity interest of Yang Infinity (“My Equity Interest”). Regarding My Equity Interest, I hereby unconditionally and irrevoc |
|
| August 30, 2019 |
Exhibit 10.5 Confirmation Letter Whereas: 1. I, Zeng Qingchun, a citizen of the People?s Republic of China, whose ID card number is ***, am a shareholder who owns 50% equity (?my equity?) in Shanghai Yibo Medical Devices Co., Ltd.; 2. I, Shanghai ECMOHO Health Biotechnology Co., Ltd. and Shanghai Yibo Medical Devices Co., Ltd. have concluded a series of agreements, including the Equity Pledge Cont |
|
| August 30, 2019 |
MOHO / ECMOHO Limited DRSLTR - - DRSLTR August 30, 2019 Via EDGAR CONFIDENTIAL U.S. Securities and Exchange Commission, Division of Corporate Finance, Office of Consumer Products, 100 F Street, N.E., Washington, D.C. 20549. Attention: Yolanda Guobadia Donna Di Silvio Jennifer Lopez-Molina Mara Ransom Re: ECMOHO Limited Draft Registration Statement on Form F-1 Confidentially submitted on June 28, 2019 CIK 0001763197 Ladies and Gen |
|
| August 30, 2019 |
Exhibit 10.17 SHARE SUBSCRIPTION AGREEMENT between ECMOHO LIMITED, and EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO Dated as of August 7, 2018 TABLE OF CONTENTS Page ARTICLE I SUBSCRIPTION OF SHARES 1.1 Subscription of Shares 1 1.2 Closing; Delivery 1 1.3 Defined Terms Used in this Agreement 1 ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE COMPANY 2.1 Organization, Good Standing, Corporate P |
|
| August 30, 2019 |
Exhibit 10.22 Share Transfer Agreement The Share Transfer Agreement (the ?Agreement?) was concluded by and among the following parties on June 25, 2019 (the ?Signing Date?): (1) Suzhou Dadehongqiang Investment Center (Limited Partnership), a limited partnership established under the laws of China and subsisting lawfully, with a residence of Room 306, Dasen Business Building, Block 1, No.368 Tongyu |
|
| August 30, 2019 |
Exhibit 10.27 Execution Version Dated 23 November 2018 IMPORT IT CORP. as Chargor and TAIPEI FUBON COMMERCIAL BANK CO., LTD. HONG KONG BRANCH as Chargee CHARGE OVER BANK ACCOUNT Table of Contents 1 Definitions and interpretation 1 2 Covenant to pay 6 3 Charges and Assignments 6 4 Set-off 7 5 Restrictions 7 6 Perfection 7 7 Enforcement 8 8 Application of proceeds 12 9 Representations and warranties |
|
| August 30, 2019 |
FORM OF INDEMNIFICATION AGREEMENT Exhibit 10.39 FORM OF INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this ?Agreement?) is made as of , 20 by and between ECMOHO Limited, an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands (the ?Company?), and (the ?Indemnitee?). WHEREAS, the Indemnitee has agreed to serve as a director or executive officer of the Company, and in suc |
|
| August 30, 2019 |
EX-10.20 13 filename13.htm Exhibit 10.20 Share Transfer Agreement The Share Transfer Agreement (the “Agreement”) was entered into by and among the following parties in Shanghai on [July] [26], 2018. Transferors: (1) Shanghai Yiheng Industrial Co., Ltd., a limited liability company established under the laws of China, with a residence of Room 148, Area A, Building 2, No.420 Fenglin Road, Xuhui Dist |
|
| August 30, 2019 |
Comprehensive Credit Line Contract Contract version number: FB201701 (applicable for companies) Exhibit 10.32 Contract No.: 1809-069382502-01 Comprehensive Credit Line Contract Contract version number: FB201701 (applicable for companies) The Contract was signed by the following parties on September 25, 2018 in Pudong New Area, Shanghai: Applicant: Shanghai Tonggou Information Technology Co., Ltd. Domicile (Address): Room 302, 3/F, 1000 Tianyaoqiao Road, Xuhui District, Shanghai Legal represe |
|
| August 30, 2019 |
Exhibit 10.35 2018 version China Merchants Bank Co., Ltd. Shanghai Branch Credit Agreement (Applicable to the case where no loan contract is separately signed for the working capital loan) 1 Credit Agreement (Applicable to the case where no loan contract is separately signed for the working capital loan) No.: 9602190301 Creditor: China Merchants Bank Co., Ltd. Shanghai Tianyaoqiao Sub-branch (here |
|
| August 30, 2019 |
Exhibit 10.11 Confirmation Letter Whereas: 1. I, Zeng Qingchun, a citizen of the People?s Republic of China, whose ID card number is ***, am a shareholder who owns 50% equity (?my equity?) in Yang infinity (Shanghai) Biotechnology Co., Limited; 2. I, Xianggui (Shanghai) Biotechnology Co., Ltd. and Yang infinity (Shanghai) Biotechnology Co., Limited have concluded a series of agreements, including |
|
| August 30, 2019 |
Equity Interest Pledge Agreement EX-10.2 2 filename2.htm Exhibit 10.2 Equity Interest Pledge Agreement This Equity Interest Pledge Agreement (this “Agreement”) is executed by and among the following parties on November 28, 2018: Pledgee: Shanghai ECMOHO Health Biotechnology Co, Ltd. Registered Address: Floor 2&3, No. 1000 Tianyaoqiao Road, Xuhui District, Shanghai Pledgors: Ying Wang (Chinese ID No.: ***) Qingchun Zeng (Chinese I |
|
| August 30, 2019 |
Exhibit 21.1 ECMOHO Limited List of Significant Subsidiaries 1. ECMOHO (Hong Kong) Health Technology Limited Hong Kong 2. ECMOHO (Hong Kong) Limited Hong Kong 3. ECMOHO Co., Ltd. Japan 4. ECMOHO Co., Ltd. Korea 5. Shanghai ECMOHO Health Biotechnology Co, Ltd. PRC 6. Yiling (Shanghai) Information Technology Co., Ltd. PRC 7. Import - It Corp. BVI 8. Yipinda (Shanghai) Health Technology Co., Ltd. PRC |
|
| August 30, 2019 |
Comprehensive Credit Line Contract Ningbo Commerce Bank (201812 Version) EX-10.36 27 filename27.htm Exhibit 10.36 NINGBO COMMERCE BANK Comprehensive Credit Line Contract Ningbo Commerce Bank (201812 Version) Comprehensive Credit Line Contract (Standard Terms) Detailed information of Party A and Party B may be found in the subsidiary terms. On the basis of equality and voluntariness, Party A and Party B have concluded the Contract upon consensus in accordance with the p |
|
| August 30, 2019 |
Exhibit 10.29 August 2016 Version Working Capital Loan Contract Contract No.: 01611 Creditor: Industrial Bank Co., Ltd. Shanghai Xuhui Sub-branch Borrower: Shanghai ECMOHO Health Biotechnology Co., Ltd. 1 Important Notes for Signing To protect your rights and interests, please carefully read, examine and confirm the following matters before signing the Contract: I. You have the right to sign the C |
|
| August 30, 2019 |
Online Self-service Loan Business Contract of Ping An Bank Exhibit 10.30 Online Self-service Loan Business Contract of Ping An Bank 1 Online Self-service Loan Business Contract of Ping An Bank Contract No.: P. Y. (Shanghai) Z. Y. D. Z. No.A454201806140001 ?under the non-comprehensive credit line (under the single credit line) ?Under the comprehensive credit line- Name of the contract: Comprehensive Credit Line Contract Contract No.: P. Y. (Shanghai) Z. Z. |
|
| August 30, 2019 |
Credit Granting Approval Notice EX-10.24 17 filename17.htm Exhibit 10.24 Credit Granting Approval Notice Date: October 18, 2018 (181018-TFB01252514) To: ECMOHO (Hong Kong) Limited Import It Corp. (the “Client”) Dear Client, Taipei Fubon Commercial Bank Co., Ltd. Hong Kong Branch (the “Bank”) will provide or extend the following line of credit (the “Credit Granting”) according to the following conditions and the General Agreement |
|
| August 30, 2019 |
Exhibit 10.26 Execution Version Dated 23 November 2018 IMPORT IT CORP. as Chargor and TAIPEI FUBON COMMERCIAL BANK, CO. LTD. HONG KONG BRANCH as Chargee CHARGE OVER RECEIVABLES Table of Contents 1 Definitions and interpretation 1 2 Covenant to pay 5 3 Charges and Assignments 5 4 Set-off 6 5 Restrictions 6 6 Perfection 7 7 Enforcement 8 8 Application of proceeds 12 9 Representations and warranties |
|
| August 30, 2019 |
Exhibit 10.37 Loan Agreement Party A (Lender): TECHLONG INTERNATIONAL INVESTMENTS LIMITED Party B (Borrower): ECMOHO (Hong Kong) Limited Party C (Guarantor): Shanghai ECMOHO Health Biotechnology Co., Ltd. Party D (Co-guarantor): Wang Ying ID No.: **** In the principle of equality, voluntariness and sincerity, Party A, Party B, Party C and Party D reach the Loan Agreement (the ?Agreement?) upon neg |
|
| August 30, 2019 |
EXCLUSIVE CALL OPTION AGREEMENT Exhibit 10.3 EXCLUSIVE CALL OPTION AGREEMENT This Exclusive Call Option Agreement (this ?Agreement?) is executed by and among the following parties on November 28, 2018: 1. Shanghai ECMOHO Health Biotechnology Co, Ltd., a limited liability company duly registered in PRC, with its address at Floor 2&3, No. 1000 Tianyaoqiao Road, Xuhui District, Shanghai (?Party A?); 2. Ying Wang, with Chinese ident |
|
| August 30, 2019 |
EX-10.34 25 filename25.htm Exhibit 10.34 Loan Agreement Party A (Lender): Shanghai Focus Brand Management Co., Ltd. Address: 17/F, 558 East Daming Road Tel.: 021-63055858 Party B (Borrower): Shanghai ECMOHO Health Biotechnology Co., Ltd. Address: 3/F, No.1000 Tianyaoqiao Road Tel.: 64172213 Party C (Guarantor): Wang Ying ID No.: **** Domicile: **** Tel.: **** Party A and Party B hereby agree as fo |
|
| June 28, 2019 |
EX-10.21 18 filename18.htm Exhibit 10.21 EXECUTION VERSION Dated the 23rd day of November 2018 BEHEALTH LIMITED (as the “Chargor ”) and TAIPEI FUBON COMMERCIAL BANK CO., LTD., HONG KONG BRANCH (as the “Chargee”) SHARE CHARGE in respect of 9,393,800 Class B Ordinary Shares of the Entire Issued Share Capital of ECMOHO LIMITED Li, Wong, Lam & W.I. Cheung Solicitors 22/F., Infinitus Plaza, 199 Des Voe |
|
| June 28, 2019 |
EX-10.11 13 filename13.htm Exhibit 10.11 INVESTORS RIGHTS AGREEMENT by and among ECMOHO LIMITED, BEHEALTH LIMITED, UHEALTH LIMITED, ECMOHO (HONG KONG) HEALTH TECHNOLOGY LIMITED, SHANGHAI ECMOHO HEALTH BIOTECHNOLOGY CO., LTD., WANG YING, ZENG QINGCHUN and EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO Dated as of August 7, 2018 TABLE OF CONTENTS Page ARTICLE I. INTRODUCTORY MATTERS 1.1 Defined Te |
|
| June 28, 2019 |
ECMOHO 2018 OMNIBUS INCENTIVE PLAN ARTICLE 1 EX-10.12 14 filename14.htm Exhibit 10.12 CONFIDENTIAL ECMOHO 2018 OMNIBUS INCENTIVE PLAN ARTICLE 1 GENERAL 1.1 Purpose The purpose of the Ecmoho 2018 Omnibus Incentive Plan (the “Plan”) is to promote the success and enhance the value of Ecmoho, a company formed under the laws of the Cayman Islands (the “Company”), by linking the personal interests of the Directors, Employees and Consultants to tho |
|
| June 28, 2019 |
EX-10.19 16 filename16.htm Exhibit 10.19 Execution Version Dated 23 November 2018 IMPORT IT CORP. as Chargor and TAIPEI FUBON COMMERCIAL BANK, CO. LTD. HONG KONG BRANCH as Chargee CHARGE OVER RECEIVABLES Table of Contents 1 Definitions and interpretation 1 2 Covenant to pay 5 3 Charges and Assignments 5 4 Set-off 6 5 Restrictions 6 6 Perfection 7 7 Enforcement 8 8 Application of proceeds 12 9 Repr |
|
| June 28, 2019 |
EX-10.7 9 filename9.htm Exhibit 10.7 JOINDER AGREEMENT This joinder agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned (the “Additional Purchaser”) in accordance with Section 1.3 of that certain Preferred Share Purchase Agreement, dated as of August 2, 2018 (the “SPA”), by and between ECMOHO Limited (the “Company”) and each of the investors listed on Exhib |
|
| June 28, 2019 |
Exhibit 21.1 ECMOHO Limited List of Significant Subsidiaries 1. ECMOHO (Hong Kong) Health Technology Limited Hong Kong 2. ECMOHO (Hong Kong) Limited Hong Kong 3. ECMOHO Co., Ltd. Korea 4. Shanghai Ecmoho Health Biotechnology Co, Ltd. PRC 5. Import-It Corp. BVI 6. Shanghai Tonggou Information Technology Co., Limited. PRC 7. Jianyikang Health Technology (Shanghai) Co., Ltd. PRC 8. Yijiasancan (Shang |
|
| June 28, 2019 |
Exclusive Technology Consulting and Service Agreement Exhibit 10.1 Exclusive Technology Consulting and Service Agreement This Exclusive Technology Consulting and Service Agreement (hereinafter referred to as the ?Agreement?) is entered into between the following parties on November 28, 2018: Party A: Shanghai ECMOHO Health Biotechnology Co, Ltd. Registration No.: 913100005886672355 Registered Address: Floor 2&3, No. 1000 Tianyaoqiao Road, Xuhui Distr |
|
| June 28, 2019 |
Exhibit 10.5 Confirmation Letter Whereas: 1. I, Ying Wang, a Chinese citizen with the ID number of ***, is the spouse of Qingchun Zeng, who is the shareholder of Shanghai Yibo Medical Devices Co., Ltd.; 1. Qingchun Zeng, Shanghai ECMOHO Health Biotechnology Co, Ltd. and Shanghai Yibo Medical Devices Co., Ltd. have entered into a series of agreements and any exhibits and amendments thereto, includi |
|
| June 28, 2019 |
As confidentially submitted to the Securities and Exchange Commission on June 28, 2019 DRS 1 filename1.htm As confidentially submitted to the Securities and Exchange Commission on June 28, 2019 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ECMOHO Limited (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant’s name into English) Cayman Islands |
|
| June 28, 2019 |
EX-10.6 8 filename8.htm Exhibit 10.6 PREFERRED SHARE PURCHASE AGREEMENT by and between ECMOHO LIMITED, ECMOHO (HONG KONG) HEALTH TECHNOLOGY LIMITED, SHANGHAI ECMOHO HEALTH BIOTECHNOLOGY CO., LTD., WANG YING, ZENG QINGCHUN, and EACH OF THE INVESTORS LISTED ON EXHIBIT A HERETO Dated as of August 2, 2018 TABLE OF CONTENTS Page ARTICLE I PURCHASE AND SALE OF PREFERRED SHARES 1.1 Sale and Issuance of P |
